Cargando…

A Novel Xeno-Free Method to Isolate Human Endometrial Mesenchymal Stromal Cells (E-MSCs) in Good Manufacturing Practice (GMP) Conditions

The cyclic regeneration of human endometrium is guaranteed by the proliferative capacity of endometrial mesenchymal stromal cells (E-MSCs). Due to this, the autologous infusion of E-MSCs has been proposed to support endometrial growth in a wide range of gynecological diseases. We aimed to compare tw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canosa, Stefano, Mareschi, Katia, Marini, Elena, Carosso, Andrea Roberto, Castiglia, Sara, Rustichelli, Deborah, Ferrero, Ivana, Gennarelli, Gianluca, Bussolati, Benedetta, Nocifora, Alberto, Asnaghi, Valentina, Bergallo, Massimiliano, Isidoro, Ciro, Benedetto, Chiara, Revelli, Alberto, Fagioli, Franca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876308/ https://www.ncbi.nlm.nih.gov/pubmed/35216052 http://dx.doi.org/10.3390/ijms23041931

Ejemplares similares

Inactivated Platelet Lysate Supports the Proliferation and Immunomodulant Characteristics of Mesenchymal Stromal Cells in GMP Culture Conditions
por: Mareschi, Katia, et al.
Publicado: (2020)

Validation of analytical methods in GMP: the disposable Fast Read 102® device, an alternative practical approach for cell counting
por: Gunetti, Monica, et al.
Publicado: (2012)

Cytokine-Induced Killer (CIK) Cells, In Vitro Expanded under Good Manufacturing Process (GMP) Conditions, Remain Stable over Time after Cryopreservation
por: Mareschi, Katia, et al.
Publicado: (2020)

Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions
por: Castiglia, Sara, et al.
Publicado: (2014)

Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use
por: Mareschi, Katia, et al.
Publicado: (2012)

Does Ovarian Endometriosis Increase Oocyte Sensitivity to ICSI-Induced Mechanical Damage?
por: Scarafia, Carlotta, et al.
Publicado: (2021)

Quinagolide Treatment Reduces Invasive and Angiogenic Properties of Endometrial Mesenchymal Stromal Cells
por: Iampietro, Corinne, et al.
Publicado: (2022)

Effect of a Combination of Myo-Inositol, Alpha-Lipoic Acid, and Folic Acid on Oocyte Morphology and Embryo Morphokinetics in non-PCOS Overweight/Obese Patients Undergoing IVF: A Pilot, Prospective, Randomized Study
por: Canosa, Stefano, et al.
Publicado: (2020)

Women in Advanced Reproductive Age: Are the Follicular Output Rate, the Follicle-Oocyte Index and the Ovarian Sensitivity Index Predictors of Live Birth in an IVF Cycle?
por: Carosso, Andrea Roberto, et al.
Publicado: (2022)

Validation of analytical methods in compliance with good manufacturing practice: a practical approach
por: Rustichelli, Deborah, et al.
Publicado: (2013)

Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity
por: Sara, Castiglia, et al.
Publicado: (2018)

Correction to: Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity
por: Castiglia, Sara, et al.
Publicado: (2018)

Impact of the addition of Early Embryo Viability Assessment to morphological evaluation on the accuracy of embryo selection on day 3 or day 5: a retrospective analysis
por: Revelli, Alberto, et al.
Publicado: (2019)

Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization
por: Bergandi, Loredana, et al.
Publicado: (2020)

Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population
por: Revelli, Alberto, et al.
Publicado: (2015)

ICSI versus Conventional IVF in Women Aged 40 Years or More and Unexplained Infertility: A Retrospective Evaluation of 685 Cycles with Propensity Score Model
por: Gennarelli, Gianluca, et al.
Publicado: (2019)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
por: Carosso, Andrea Roberto, et al.
Publicado: (2021)

Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone
por: Canosa, Stefano, et al.
Publicado: (2022)

Reproductive and Obstetric Outcomes Following a Natural Cycle vs. Artificial Endometrial Preparation for Frozen–Thawed Embryo Transfer: A Retrospective Cohort Study
por: Carosso, Andrea Roberto, et al.
Publicado: (2023)

Expectant Management Before In vitro Fertilization in Women Aged 39 or Above and Unexplained Infertility Does Not Decrease Live Birth Rates Compared to Immediate Treatment
por: Carosso, Andrea Roberto, et al.
Publicado: (2021)

Myogenic Potential of Whole Bone Marrow Mesenchymal Stem Cells In Vitro and In Vivo for Usage in Urinary Incontinence
por: Gunetti, Monica, et al.
Publicado: (2012)

Innovative Strategies for Fertility Preservation in Female Cancer Survivors: New Hope from Artificial Ovary Construction and Stem Cell-Derived Neo-Folliculogenesis
por: Canosa, Stefano, et al.
Publicado: (2023)

The Ovarian Sensitivity Index (OSI) Significantly Correlates with Ovarian Reserve Biomarkers, Is More Predictive of Clinical Pregnancy than the Total Number of Oocytes, and Is Consistent in Consecutive IVF Cycles
por: Revelli, Alberto, et al.
Publicado: (2020)

Xeno-Hybrid Bone Graft Releasing Biomimetic Proteins Promotes Osteogenic Differentiation of hMSCs
por: Zhu, Hao, et al.
Publicado: (2020)

Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles: a pilot study
por: Carosso, Andrea, et al.
Publicado: (2020)

Diverse impact of xeno-free conditions on biological and regenerative properties of hUC-MSCs and their extracellular vesicles
por: Bobis-Wozowicz, Sylwia, et al.
Publicado: (2016)

Effect of In Vitro Exposure of Corticosteroid Drugs, Conventionally Used in AMD Treatment, on Mesenchymal Stem Cells
por: Nuzzi, Raffaele, et al.
Publicado: (2012)

Xeno-Free In Vitro Cultivation and Osteogenic Differentiation of hAD-MSCs on Resorbable 3D Printed RESOMER(®)
por: Kirsch, Marline, et al.
Publicado: (2020)

Derivation of Xeno-Free and GMP-Grade Human Embryonic Stem Cells – Platforms for Future Clinical Applications
por: Tannenbaum, Shelly E., et al.
Publicado: (2012)

Xeno-free protocol for GMP-compliant manufacturing of human fetal pancreas-derived mesenchymal stem cells
por: Jabbarpour, Zahra, et al.
Publicado: (2022)

A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions Preserves the Chemical Characteristics and Biological Activity of Lyo-Secretome Isolated by Ultrafiltration
por: Mareschi, Katia, et al.
Publicado: (2022)

Long Term Expansion of Bone Marrow-Derived hMSCs on Novel Synthetic Microcarriers in Xeno-Free, Defined Conditions
por: Hervy, Martial, et al.
Publicado: (2014)

Induction of functional xeno-free MSCs from human iPSCs via a neural crest cell lineage
por: Kamiya, Daisuke, et al.
Publicado: (2022)

GMP-compatible and xeno-free cultivation of mesenchymal progenitors derived from human-induced pluripotent stem cells
por: McGrath, Madison, et al.
Publicado: (2019)

Long-Term Efficacy of GMP Grade Xeno-Free hESC-Derived RPE Cells Following Transplantation
por: McGill, Trevor J., et al.
Publicado: (2017)

Organotypic spinal cord cultures: An in vitro 3D model to preliminary screen treatments for spinal muscular atrophy
por: Boido, Marina, et al.
Publicado: (2021)

A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions
por: Mareschi, Katia, et al.
Publicado: (2022)

Is There a Noninvasive Source of MSCs Isolated with GMP Methods with Better Osteogenic Potential?
por: Pinheiro, Carla C. G., et al.
Publicado: (2019)

A New Paclitaxel Formulation Based on Secretome Isolated from Mesenchymal Stem Cells Shows a Significant Cytotoxic Effect on Osteosarcoma Cell Lines
por: Banche Niclot, Alessia Giovanna Santa, et al.
Publicado: (2023)

Precision Medicine in Osteosarcoma: MATCH Trial and Beyond
por: Tirtei, Elisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m17req08jfcv19124u53r1ip4h